Company Profile
Recent Developments
   

Senior Management
Mark A. Varney, Ph.D.
President and CEO
James H. Coleman
Senior Vice President of Business Development
Steven A. Johnson, Ph.D.
Vice President, Preclinical Development
Maria S. Messinger
Vice President, Chief Financial Officer and Corporate Secretary
Roger G. Stoll, Ph.D.
Executive Chairman
Pierre V. Trân, M.D., M.M.M.
Chief Medical Officer and Vice President, Clinical Development
   
Board of Directors
Robert F. Allnutt
John F. Benedik
Charles J. Casamento
Carl W. Cotman, Ph.D.
Peter F. Drake, Ph.D.
M. Ross Johnson, Ph.D.
Roger G. Stoll, Ph.D.
Gary D. Tollefson, M.D., Ph.D.
Mark A. Varney, Ph.D.
   
Scientific Advisors
Arvid Carlsson, M.D., Ph.D.
Gary S. Lynch, Ph.D.
   
Market Overview and Business Strategy
Respiratory Depression
Attention Deficit Hyperactivity Disorder (ADHD)
Alzheimer's Disease
   
Business Development
Business Strategy
Corporate Partnership
University Affiliates